Wilkowska A

Department of Psychiatry, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.

8 papers · ORCID

ArticleKetamine

Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions.

Wilkowska A, Nizgorska-Ohler J, Cubała WJ

Europe PMC2026
ArticleKetamine

Treatment-emergent psychiatric adverse events in patient-reported outcomes during ketamine use for major depressive disorder: a retrospective analysis.

Kwaśny A, Wilkowska A, Pastuszak M +2

Europe PMC2026
ArticleKetamine

Ketamine dosing formula in treatment-resistant bipolar depression.

Kwaśny A, Jerzy Cubała W, Wilkowska A

Europe PMC2025
ArticleKetamine

The Need for Guidance on Ketamine/Esketamine Use in Real-World Clinical Settings.

Wilkowska A, Cubała WJ

Europe PMC2025
ArticleKetamine

Comment on "Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis".

Wilkowska A, Cubała WJ

Europe PMC2025
ArticleDMT

Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials.

Kwaśny A, Wilkowska A, Cubała WJ

Europe PMC2024
ArticleKetamine

Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review.

Kwaśny A, Kwaśna J, Wilkowska A +4

Europe PMC2024
ArticleKetamine

Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management.

Wilkowska A, Cubała WJ

Europe PMC2023